Inventor
PRESTRELSKI STEVEN J
US17 patents
⚠️ This page may combine multiple inventors who share the name “PRESTRELSKI STEVEN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALZA CORP
8 patentsUS6235712B1May 22, 2001
Non-aqueous polar aprotic peptide formulations
ALZA CORP113 citations98
US6124261ASep 26, 2000
Non-aqueous polar aprotic peptide formulations
ALZA CORP146 citations98
US5972369AOct 26, 1999
Diffusional implantable delivery system
ALZA CORP260 citations98
US5932547AAug 3, 1999
Non-aqueous polar aprotic peptide formulations
ALZA CORP151 citations98
US5981489ANov 9, 1999
Non-aqueous protic peptide formulations
ALZA CORP48 citations95
US6068850AMay 30, 2000
Aqueous formulations of peptides
ALZA CORP33 citations92
US6066619AMay 23, 2000
Non-aqueous protic peptide formulations
ALZA CORP19 citations92
US5916582AJun 29, 1999
Aqueous formulations of peptides
ALZA CORP19 citations92
XERIS PHARMACEUTICALS INC
7 patentsUS9642894B2May 9, 2017
Compositions for rapidly treating severe hypoglycemia
XERIS PHARMACEUTICALS INC5 citations83
US9125805B2Sep 8, 2015
Stable formulations for parenteral injection of small molecule drugs
XERIS PHARMACEUTICALS INC12 citations80
US11446310B2Sep 20, 2022
Stable formulations for parenteral injection of small molecule drugs
XERIS PHARMACEUTICALS INC1 citations69
US11020403B2Jun 1, 2021
Precipitation resistant small molecule drug formulations
XERIS PHARMACEUTICALS INC4 citations67
US9018162B2Apr 28, 2015
Methods for rapidly treating severe hypoglycemia
XERIS PHARMACEUTICALS INC3 citations62
US11833157B2Dec 5, 2023
Precipitation resistant small molecule drug formulations
XERIS PHARMACEUTICALS INC0 citations56
US10765683B2Sep 8, 2020
Stable formulations for parenteral injection of small molecule drugs
XERIS PHARMACEUTICALS INC0 citations48